Cargando…

A simple reverse genetics method to generate recombinant coronaviruses

Engineering recombinant viruses is a pre‐eminent tool for deciphering the biology of emerging viral pathogens such as the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). However, the large size of coronavirus genomes renders the current reverse genetics methods challenging. Here, we de...

Descripción completa

Detalles Bibliográficos
Autores principales: Mélade, Julien, Piorkowski, Géraldine, Touret, Franck, Fourié, Toscane, Driouich, Jean‐Sélim, Cochin, Maxime, Bouzidi, Hawa Sophia, Coutard, Bruno, Nougairède, Antoine, de Lamballerie, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066064/
https://www.ncbi.nlm.nih.gov/pubmed/35239997
http://dx.doi.org/10.15252/embr.202153820
_version_ 1784699724928909312
author Mélade, Julien
Piorkowski, Géraldine
Touret, Franck
Fourié, Toscane
Driouich, Jean‐Sélim
Cochin, Maxime
Bouzidi, Hawa Sophia
Coutard, Bruno
Nougairède, Antoine
de Lamballerie, Xavier
author_facet Mélade, Julien
Piorkowski, Géraldine
Touret, Franck
Fourié, Toscane
Driouich, Jean‐Sélim
Cochin, Maxime
Bouzidi, Hawa Sophia
Coutard, Bruno
Nougairède, Antoine
de Lamballerie, Xavier
author_sort Mélade, Julien
collection PubMed
description Engineering recombinant viruses is a pre‐eminent tool for deciphering the biology of emerging viral pathogens such as the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). However, the large size of coronavirus genomes renders the current reverse genetics methods challenging. Here, we describe a simple method based on “infectious subgenomic amplicons” (ISA) technology to generate recombinant infectious coronaviruses with no need for reconstruction of the complete genomic cDNA and apply this method to SARS‐CoV‐2 and also to the feline enteric coronavirus. In both cases we rescue wild‐type viruses with biological characteristics similar to original strains. Specific mutations and fluorescent red reporter genes can be readily incorporated into the SARS‐CoV‐2 genome enabling the generation of a genomic variants and fluorescent reporter strains for in vivo experiments, serological diagnosis, and antiviral assays. The swiftness and simplicity of the ISA method has the potential to facilitate the advance of coronavirus reverse genetics studies, to explore the molecular biological properties of the SARS‐CoV‐2 variants, and to accelerate the development of effective therapeutic reagents.
format Online
Article
Text
id pubmed-9066064
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-90660642022-05-04 A simple reverse genetics method to generate recombinant coronaviruses Mélade, Julien Piorkowski, Géraldine Touret, Franck Fourié, Toscane Driouich, Jean‐Sélim Cochin, Maxime Bouzidi, Hawa Sophia Coutard, Bruno Nougairède, Antoine de Lamballerie, Xavier EMBO Rep Reports Engineering recombinant viruses is a pre‐eminent tool for deciphering the biology of emerging viral pathogens such as the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). However, the large size of coronavirus genomes renders the current reverse genetics methods challenging. Here, we describe a simple method based on “infectious subgenomic amplicons” (ISA) technology to generate recombinant infectious coronaviruses with no need for reconstruction of the complete genomic cDNA and apply this method to SARS‐CoV‐2 and also to the feline enteric coronavirus. In both cases we rescue wild‐type viruses with biological characteristics similar to original strains. Specific mutations and fluorescent red reporter genes can be readily incorporated into the SARS‐CoV‐2 genome enabling the generation of a genomic variants and fluorescent reporter strains for in vivo experiments, serological diagnosis, and antiviral assays. The swiftness and simplicity of the ISA method has the potential to facilitate the advance of coronavirus reverse genetics studies, to explore the molecular biological properties of the SARS‐CoV‐2 variants, and to accelerate the development of effective therapeutic reagents. John Wiley and Sons Inc. 2022-03-03 /pmc/articles/PMC9066064/ /pubmed/35239997 http://dx.doi.org/10.15252/embr.202153820 Text en © 2022 Unité des Virus Emergents. Published under the terms of the CC BY 4.0 license https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Reports
Mélade, Julien
Piorkowski, Géraldine
Touret, Franck
Fourié, Toscane
Driouich, Jean‐Sélim
Cochin, Maxime
Bouzidi, Hawa Sophia
Coutard, Bruno
Nougairède, Antoine
de Lamballerie, Xavier
A simple reverse genetics method to generate recombinant coronaviruses
title A simple reverse genetics method to generate recombinant coronaviruses
title_full A simple reverse genetics method to generate recombinant coronaviruses
title_fullStr A simple reverse genetics method to generate recombinant coronaviruses
title_full_unstemmed A simple reverse genetics method to generate recombinant coronaviruses
title_short A simple reverse genetics method to generate recombinant coronaviruses
title_sort simple reverse genetics method to generate recombinant coronaviruses
topic Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066064/
https://www.ncbi.nlm.nih.gov/pubmed/35239997
http://dx.doi.org/10.15252/embr.202153820
work_keys_str_mv AT meladejulien asimplereversegeneticsmethodtogeneraterecombinantcoronaviruses
AT piorkowskigeraldine asimplereversegeneticsmethodtogeneraterecombinantcoronaviruses
AT touretfranck asimplereversegeneticsmethodtogeneraterecombinantcoronaviruses
AT fourietoscane asimplereversegeneticsmethodtogeneraterecombinantcoronaviruses
AT driouichjeanselim asimplereversegeneticsmethodtogeneraterecombinantcoronaviruses
AT cochinmaxime asimplereversegeneticsmethodtogeneraterecombinantcoronaviruses
AT bouzidihawasophia asimplereversegeneticsmethodtogeneraterecombinantcoronaviruses
AT coutardbruno asimplereversegeneticsmethodtogeneraterecombinantcoronaviruses
AT nougairedeantoine asimplereversegeneticsmethodtogeneraterecombinantcoronaviruses
AT delamballeriexavier asimplereversegeneticsmethodtogeneraterecombinantcoronaviruses
AT meladejulien simplereversegeneticsmethodtogeneraterecombinantcoronaviruses
AT piorkowskigeraldine simplereversegeneticsmethodtogeneraterecombinantcoronaviruses
AT touretfranck simplereversegeneticsmethodtogeneraterecombinantcoronaviruses
AT fourietoscane simplereversegeneticsmethodtogeneraterecombinantcoronaviruses
AT driouichjeanselim simplereversegeneticsmethodtogeneraterecombinantcoronaviruses
AT cochinmaxime simplereversegeneticsmethodtogeneraterecombinantcoronaviruses
AT bouzidihawasophia simplereversegeneticsmethodtogeneraterecombinantcoronaviruses
AT coutardbruno simplereversegeneticsmethodtogeneraterecombinantcoronaviruses
AT nougairedeantoine simplereversegeneticsmethodtogeneraterecombinantcoronaviruses
AT delamballeriexavier simplereversegeneticsmethodtogeneraterecombinantcoronaviruses